NAUT
NAUTILUS BIOTECH (NAUT)
NASDAQ
$2.62-$0.06 (-2.16%)
Price as of Jun 03, 2026 7:55 PM EDT
  • $348.2M
    Market Cap
  • 249.05%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-41.1M
-18.56%
-50.5M
+6.83%
-47.3M
+25.43%
-37.7M
+28.35%
Depreciation and Amortization Expense
1.7M
-13.92%
2.0M
+6.81%
1.8M
+51.93%
1.2M
+19.43%
Total Operating Expenses
66.8M
-17.97%
81.5M
+6.99%
76.2M
+19.70%
63.6M
+25.98%
Operating Profit
-59.0M
-16.64%
-70.8M
+11.16%
-63.7M
+9.93%
-57.9M
+15.12%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
-10.8M
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
+100.00%
-10.8M
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
7.8M
-26.74%
10.7M
-14.27%
12.5M
+119.13%
5.7M
+3,011.48%
Income before Taxes
-59.0M
-16.64%
-70.8M
+11.16%
-63.7M
+9.93%
-57.9M
+15.12%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-59.0M
-16.64%
-70.8M
+11.16%
-63.7M
+9.93%
-57.9M
+15.12%
Net Income from Continuing Operations Applicable to Common
-59.0M
-16.64%
-70.8M
+11.16%
-63.7M
+9.93%
-57.9M
+15.12%
Basic EPS and Net Income
-0.47
-16.07%
-0.56
+9.80%
-0.51
+10.87%
-0.46
-23.33%
Diluted EPS and Net Income
-0.47
-16.07%
-0.56
+9.80%
-0.51
+10.87%
-0.46
-23.33%
Basic Weighted Average Shares
126.3M
+0.66%
125.4M
+0.41%
124.9M
+0.26%
124.6M
+47.51%
Diluted Weighted Average Shares
126.3M
+0.66%
125.4M
+0.41%
124.9M
+0.26%
124.6M
+47.51%
Balance Sheet
Cash and Cash Equivalents
12.4M
-55.19%
27.6M
+42.53%
19.4M
-83.06%
114.5M
-38.30%
Short-Term Investments
91.0M
-10.98%
102.2M
-33.61%
154.0M
+120.19%
69.9M
-56.31%
Cash and Cash Equivalents and Short-Term Investments
103.4M
-20.39%
129.9M
-25.10%
173.4M
-5.99%
184.5M
-46.64%
Total Current Assets
106.0M
-20.22%
132.8M
-24.89%
176.8M
-5.54%
187.2M
-46.39%
Accumulated Depreciation
8.1M
+24.29%
6.5M
+41.00%
4.6M
+56.40%
3.0M
+48.60%
Property and Plant and Equipment and Net
3.5M
-15.19%
4.1M
-4.48%
4.3M
+15.32%
3.7M
+49.01%
Total Long-Term Assets
1.2M
0.00%
1.2M
0.00%
1.2M
+6.50%
1.1M
+11.13%
Total Assets
191.1M
-21.27%
242.7M
-20.56%
305.6M
-12.71%
350.1M
-12.15%
Income Taxes Payable
0
N/A
0
N/A
0
N/A
0
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.0M
+4.19%
7.6M
-16.33%
9.1M
+34.32%
6.8M
+16.84%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
26.2M
-0.74%
26.4M
-15.15%
31.1M
+9.72%
28.3M
-2.49%
Total Liabilities
34.1M
+0.37%
34.0M
-15.42%
40.2M
+14.47%
35.1M
+0.73%
Retained Earnings
-332.0M
+21.61%
-273.0M
+35.00%
-202.2M
+45.95%
-138.6M
+71.83%
Total Stockholders Equity
157.0M
-24.80%
208.7M
-21.34%
265.4M
-15.74%
314.9M
-13.38%
Total Shares Outstanding
126.5M
+0.29%
126.1M
+0.83%
125.1M
+0.16%
124.9M
+0.45%
Cash Flow
Cash from Operating Activities
-50.7M
-14.29%
-59.1M
+14.38%
-51.7M
+12.89%
-45.8M
+16.73%
Capital Expenditures
1.3M
-39.82%
2.1M
-13.10%
2.4M
+5.08%
2.3M
+2.42%
Cash from Investing Activities
35.2M
-46.83%
66.3M
+251.48%
-43.7M
+69.91%
-25.7M
-81.48%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
214,000
-81.29%
1.1M
+210.87%
368,000
-34.52%
562,000
-99.83%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-27.20%
+5.35%
-25.82%
+32.91%
-19.42%
+25.50%
-15.48%
-15.51%
Return on Equity
-32.27%
+8.06%
-29.86%
+36.06%
-21.95%
+28.54%
-17.07%
-37.46%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
13.33
-23.43%
17.40
-10.22%
19.39
-29.68%
27.57
-54.12%
Cash Ratio
1.56
-57.00%
3.62
+70.35%
2.13
-87.39%
16.86
-47.20%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow